Clavijo, P. E., Friedman, J., Robbins, Y., Moore, E. C., Smith, E., Zauderer, M., . . . Allen, C. T. (2018). Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function. Cancer Immunol Res.
Chicago Style CitationClavijo, Paul E., Jay Friedman, Yvette Robbins, Ellen C. Moore, Ernest Smith, Maurice Zauderer, Elizabeth E. Evans, i Clint T. Allen. "Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade Via Attenuation of MDSC Recruitment and Function." Cancer Immunol Res 2018.
Cita MLAClavijo, Paul E., et al. "Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade Via Attenuation of MDSC Recruitment and Function." Cancer Immunol Res 2018.
Atenció: Aquestes cites poden no estar 100% correctes.